Skip to main content
. 2020 Feb 28;11:1112. doi: 10.1038/s41467-020-14916-7

Fig. 2. ESC SEs acquired CpG methylation in different patterns as primed pluripotency is established.

Fig. 2

a CpG methylation along three representative SEs in embryonic stem cells (ESCs; serum/LIF)11 and epiblast stem cells (EpiSCs; this study) in CDM supplemented with activin A and fibroblast growth factor 2 as represented in Fig. 1a. Unmethylated SE subregions that gain methylation in EpiSCs are represented as magenta bars (DM subregions), and those that remain unmethylated as green bars (PU subregions). Grey bars represent interstitial (INT) regions in ESCS that remain methylated in EpiSCs. b Proportion (%) of SE subregions in ESCs and EpiSCs. Unmethylated regions in ESCs (blue bar) either remain unmethylated (PU, green, 184 subregions) or become methylated (DM, magenta, 492 subregions) in EpiSCs; INT (547 subregions) methylated regions are shown in grey. A total of 231 SEs were analysed. c CpG methylation levels (mCpG/CpG) at PU, DM and INT subregions in an independent ESC line grown in serum/LIF (ser)14, in EpiLCs and an independent EpiSC line23. ESCs grown in 2i/LIF (2i)11 are also shown; 2i/LIF conditions enforce a globally hypomethylated state of genome. d CpG methylation levels (mCpG/CpG) at PU, DM and INT subregions in vivo in pre-implantation (inner cell mass (ICM); E3.5 and E4.0) and post-implantation epiblast (Epi; E5.5 and E6.5) tissues22.